Volitionrx Limited (VNRX) Misses Q2 EPS by 1c
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
- Rockwell Automation (ROK) Said to Attract Takeover Interest from Schneider Electric - Source
- British American Tobacco Offers to Acquire Remaining Shares of Reynolds American (RAI) for $56.50/Share
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Volitionrx Limited (NYSE: VNRX) reported Q2 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter
- Stifel Upgrades PayPal (PYPL) to Buy Following 'Solid' Q3 Results
- UPDATE: Honeywell (HON) Reports In-Line Q3 EPS; Issues Q4 EPS outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!